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Background: Stenotrophomonas maltophila has emerged as an
important nosocomial pathogen capable of causing respiratory,
urinary and bloodstream infections in immuno-compromised indi-
viduals. This study evaluates the activities of antimicrobial agents
use for treating infections caused by S. maltophila.
Methods & Materials: Amikacin, aztreonam, cefepime,
ciproﬂoxacin, piperacillin-tazobactam, ceftazidime, imipenem,
and meropenem were used to prepare antibiotic stock solutions
as described by CLSI. A 1:10 dilution was made of each antibiotic
stock solution to obtain a ﬁnal concentration of 2,560g/mL. An
agar dilution series (0.125-512g/mL) was set-up according to
CLSI procedure. The MICs and MBCs of antibiotics used were deter-
mined by broth microdilution method as described by CLSI, and
CLSI criteria used for interpretation. Activities of three two-drug
combinations against 39 of these isolates were analyzed using the
checkerboard synergy test.
Results:Among the total of 95 tentative S.maltophila, by cultural
and morphology characteristic, 85 were identiﬁed as S. maltophila
by the specie-speciﬁc primer employing PCR assaywhichwasmore
sensitive. MICs and MBCs values of all isolates were determined
(n=85). The MBC values were generally equal or one to three times
greater than those of MIC. All 85 isolates analyzed were resis-
tant to more than three anti-Stenotrophomonas agents. Thirty-nine
(n=39) multidrug resistant (MDR) strains were randomly selected
for synergy testing using clinically relevant antibiotics included in
the screening panel. Stenotrophomonas isolates were found to be
MDR to amikacin, aztreonam, piperacillin, piperacillin-tazobactam,
cefepime, ceftazidime, imipenem and meropenem. Five (12.82%)
of the test isolates were sensitive to amikacin and aztreonan. Ten
(25.64%) were sensitive to piperacillin; 8(20.51%) to piperacillin-
tazobactam and cefepime; 9(23.07%) to ceftazidime; and 7(17.95%)
to imipenem and meropenem. Statistically signiﬁcant indiffer-
ence interaction was observed with aztreonam, piperacillin, and
piperacillin-tazobactam in combination with amikacin p values
0.0018, 0.0012, and 0.0001 respectively. Cefepime, imipenem
and meropenem in combination with amikacin resulted in sta-
tistically signiﬁcant in vitro antibiotics synergy interaction; p
values 0.0001, < 0.0001and<0.0001 respectively. A combination
of ceftazidime with amikacin resulted in signiﬁcant antagonistic
interaction p<0.0001.
Conclusion: The ﬁndings of this study demonstrate the poten-
tial value and necessity of closely monitoring multidrug-resistant
pathogens in an efﬂuent environment giving their public health
signiﬁcance
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Background: Streptococcus pyogenes (Group A streptococcus,
GAS) is an important pathogen responsible for skin and soft tis-
sue infections including life threatening invasive infections such
as necrotizing fasciitis and toxic shock syndrome. Streptococcal
pyrogenic exotoxins A, B and C are known to be involved in patho-
genesis and virulence of GAS infections. A study was conducted
in a tertiary care hospital, to assess the prevalence, predisposing
factors, antibiotic susceptibility patterns & to detect Streptococcal
pyrogenic exotoxin B gene (speB) by Polymerase Chain Reaction
(PCR).
Methods & Materials: A prospective study was conducted on
pus, wound swab & body ﬂuids from August 2008 to January
2010 at Kasturba Medical College, Mangalore. The specimens were
inoculated into enriched media (5% sheep blood agar & chocolate
agar) and enrichment broths. The obtained isolates were further
conﬁrmedas Streptococcus pyogenesbybiochemical reactions,wide
zone of inhibition around Bacitracin disc and using latex aggluti-
nation. Antibiotic susceptibility test was performed on conﬁrmed
isolates by modiﬁed Kirby Bauer disc diffusion method, Mueller-
Hinton agar supplemented with 5% sheep blood. The detection of
gene (spe B) encoding for streptococcal pyrogenic exotoxin Bwas
done by PCR.
Results: A total of 3606 pus, wound swab, throat swab & blood
culture samples were received during the study period. Overall
streptococcal prevalence rate was 4.7% (n=171). GAS was the pre-
dominant isolate with a prevalence rate of 1.69% (n=61). Cellulitis
was themost common infection (27.8%,n =17). Themost commonly
affected age group was 21-60 years with a mean and median age
around 41, majority being males(72.1%, n =44) and diabetes mel-
litus was the most common predisposing condition(31.1%, n =19).
All GAS isolates were susceptible to penicillin & highest resistance
was observed to erythromycin (14.75%).In our study, the occur-
rence of chromosomally encoded spe B genes was high. speB gene
was present in all GAS isolates.
Conclusion:Our study indicates that Streptococcus pyogenes is
a common infection in diabetics with cellulitis and all the strains
were susceptible to penicillin. A need for rapid diagnosis of the
infection has been felt. speB gene is prevalent in all GAS isolates
from skin and soft tissue infections and could be used as a means
for rapid diagnosis of Streptococcus pyogenes.
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